Further investigation of ALDH1A1, MAOA, and particularly KLF4 in a patient cohort is warranted, and their involvement in maintaining cancer stem cell populations could lead to novel areas of investigation for non-surgical treatment of EEC and LNG resistance. The gene discussed is ALDH1A1; the disease is cancer.